4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-018325
Chief Accounting Officer sold 1,000 shares at $26.00 ($26,000)
- Chief Accounting Officer acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas Chief Accounting Officer | 2024-02-16 | Option exercise 10b5-1 | +1,000 | $11.35 | $11,350 | 7,774 | D |
| Lyon Joseph Douglas Chief Accounting Officer | 2024-02-16 | Sale 10b5-1 | −1,000 | $26.00 | $26,000 | 6,774 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas Chief Accounting Officer | 2024-02-16 | Option exercise · Stock option (right to buy) 10b5-1 | −1,000 | 43,167 | D | ||
| Open-market sales · 1,000 sh · avg $26.00 · $26,000 | |||||||
Loading xslF345X05/ownership.xml…